Lab data

Semaglutide test results: how often vials pass lab testing

Four in ten recent research semaglutide samples failed lab testing. Here are the numbers, what a peer-reviewed study of online semaglutide found, and why none of it describes Ozempic or Wegovy.

12 November 2026 3 min read By Peptide AI Editorial policy

Of the last 192 Semaglutide samples with a result in Finnrick's public lab-testing database, 116 passed and 76 failed: 60 percent of Semaglutide test results were a pass. Another 8 came back incomplete and are left out. Finnrick has published 387 Semaglutide tests from 77 sellers since 17 Dec 2024.

Semaglutide is fully FDA-approved: as Ozempic and Rybelsus for type 2 diabetes, and as Wegovy for chronic weight management. The results here are of semaglutide sold online with a research-use-only label, which is not any of those products.

The short version

  • 60 percent of recent samples passed. 116 passed and 76 failed, of the last 192 with a result.
  • The molecule is FDA-approved as Ozempic, Rybelsus and Wegovy. A research-labelled vial is none of them.
  • A pass is a narrow result. It covers identity, purity and fill for the vial that was tested. It does not cover endotoxin, sterility or the next batch.
  • We do not name sellers. The numbers describe the market, not any one shop.

Semaglutide test results in numbers

MeasureSemaglutide
Published tests387
Sellers with at least one test77
First and latest test17 Dec 2024 to 2 Nov 2026
Recent results counted192 (8 incomplete left out)
Passed116
Failed76
Pass rate60%
Rank by pass rate7 of 14 on our peptide test results page

Figures from Finnrick's public Semaglutide page, checked on 12 November 2026. They will change as new results come in.

What counts as a pass or a fail

These figures use Finnrick's "Purity focus" standard, the one its public pages show. A sample passes when its purity is at least 99.5 percent and the amount in the vial is within 35 percent of the label. A sample that turns out to be a different molecule fails under every standard Finnrick uses. Endotoxin testing is not required under this standard, so a pass says nothing about endotoxin or sterility.

The pass rate counts passes and fails among the most recent results on Finnrick's public page, up to 200, and leaves out tests that came back incomplete. Finnrick says it sources samples from sellers and sends them to third-party labs, with HPLC as the main method. Its methodology page has the detail.

Is semaglutide FDA-approved?

Yes (see our semaglutide page). Compounding pharmacies could make copies while semaglutide was on FDA's shortage list. FDA determined that shortage resolved in February 2025 and compounders' grace periods have since ended. Our page on the compounded GLP-1 crackdown has the timeline.

What else is known about online semaglutide

Of the last 192 semaglutide samples with a result, 76 failed. Finnrick has published 387 semaglutide tests from 77 sellers since 17 Dec 2024.

A peer-reviewed study backs the pattern. Ashraf and colleagues bought semaglutide from online sellers without a prescription in 2024 and measured content 28.56 to 38.69 percent above the label, with endotoxin in every sample. It was small, and it is not about research-labelled vials. Our page on sourcing and purity sets out both studies we cite.

Before you buy Semaglutide

Semaglutide is an approved medicine, so a prescription filled by a licensed pharmacy is the safer route. Peptide AI's prescription route through licensed telehealth is coming soon.

Before any order, three checks come first: the steps in how to vet a peptide supplier, an independent result for your own lot (how to get peptides tested), and the legal picture in is it legal to buy peptides. Products sold as research use only are not FDA-approved drugs, and a passing test does not make one safe to use.

Peptide AI is building a marketplace with two ways to buy: on a prescription through licensed telehealth, for what can legally be prescribed, or from vetted suppliers with an independent lab report you read before you order. It is not open yet. Early access is here.

Questions people ask

What percentage of Semaglutide fails lab testing?

In Finnrick's public test database, 76 of the last 192 Semaglutide samples with a result failed, which is 40 percent, and 116 passed. Tests that came back incomplete are left out.

Is Semaglutide FDA-approved?

The molecule is FDA-approved as Ozempic, Rybelsus and Wegovy. A research-labelled vial is none of them.

Does a passing lab test mean Semaglutide is safe?

No. A pass means the sample matched its label on identity, purity and fill under one standard. It does not cover endotoxin, sterility, other vials, or whether Semaglutide is safe or does anything in people.

Is research semaglutide the same as Ozempic or Wegovy?

It carries the same molecule name, but it is a different product. Ozempic and Wegovy are approved drugs. A research-labelled vial is not, and 76 of the last 192 tested samples failed.

Sources

  1. Methodology, Finnrick, accessed 12 November 2026
  2. Semaglutide product page and public test history, Finnrick, accessed 12 November 2026
  3. Multifactor quality and safety analysis of semaglutide products sold by online sellers without a prescription, Ashraf et al., Journal of Medical Internet Research, 2024
Free on iOS and Android

Log it once. See it all on one timeline.

Doses, food, training, labs, sleep and scans on one timeline. On iOS and Android.

The PeptideAI protocol screen with a weekly GLP-1 dose on it.